Pharmacy News

The opinion is for the indication of RCC, the most common kind of kidney cancer found in adults.

The therapy has already produced encouraging results in pre-clinical studies and regulatory toxicology tests in preparation for first-in-human clinical trials.

The funding is available are part of the Government’s modern Industrial Strategy.

NICE reviewed a BMJ study and determined that the findings suggest that guidance on antibiotic use is not being implemented as well as it could be in all areas which may lead to antibiotic overuse.

A shockingly high number of dogs, mice, cats, rabbits and other animals are still suffering in invasive, painful and sometimes lethal experiments in British laboratories.

Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO

The antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties.

Under the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of EUR 45million and is eligible to receive up to more than EUR 1.1billion in potential payments.

ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord.

The governing body accepted the company's Biologics License Application for prevention of vaso-occlusive crises.

More than 85% of companies have no women executives on their main boards, only 9% of executive directors on main boards are women, and a mere 17% of FTSE350 executive committee members are women.

During the pilot over the last seven months over 1,000 customers accessed the service, with the majority of them completing the service in the same day.

The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention.

The candidate, LYT-100, demonstrated anti-fibrotic and anti-inflammatory mechanisms in pre-clinical studies.

AMAL’s lead vaccine, ATP128, is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month.

Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments.

NICE has recommended Novartis’ Kisqali just three months after its initial rejection.

The ‘toolkit’, will be available to help companies implement the FAIR guiding principles for data management and stewardship.

A new ‘transfer window’ lets staff move within the NHS between areas while developing new skills.

Financial terms of the transaction have not been disclosed and are expected to have a minimal impact on revenue and earnings in the current financial year.